Antigens
New research from Emory University School of Medicine has found that all currently available influenza tests are capable of detecting 2024 U.S. H5N1 strains in contrived samples, with varying degrees of analytical sensitivity. The study, published in the Journal of Clinical Microbiology, assessed the ability of 10 commercially available
Antigens
New research from Emory University School of Medicine has found that all currently available influenza tests are capable of detecting 2024 U.S. H5N1 strains in contrived samples, with varying degrees of analytical sensitivity. The study, published in the Journal of Clinical Microbiology, assessed the ability of 10 commercially available
Antigens
The landscape of cancer treatment is rapidly evolving with the emergence of chimeric antigen receptor (CAR) T-cell therapy, a cutting-edge approach that holds promise for patients with certain types of cancer. Researchers at the City of Hope National Medical Center have highlighted the importance of advanced practice nurses (APNs) in
Antigens
New research from Emory University School of Medicine has found that all currently available influenza tests are capable of detecting 2024 U.S. H5N1 strains in contrived samples, with varying degrees of analytical sensitivity. The study, published in the Journal of Clinical Microbiology, assessed the ability of 10 commercially available
Antigens
The landscape of cancer treatment is rapidly evolving with the emergence of chimeric antigen receptor (CAR) T-cell therapy, a cutting-edge approach that holds promise for patients with certain types of cancer. Researchers at the City of Hope National Medical Center have highlighted the importance of advanced practice nurses (APNs) in
Antigens
Research has shed new light on the genetic factors contributing to pulmonary tuberculosis (PTB) susceptibility in the Thai population, revealing a significant association between CTLA-4 gene polymorphisms, particularly CTLA4+6230A/G, and the risk of PTB. The study, conducted by researchers from Srinakharinwirot University, used polymerase chain reaction-restriction fragment length
T cells
Research has shed new light on the genetic factors contributing to pulmonary tuberculosis (PTB) susceptibility in the Thai population, revealing a significant association between CTLA-4 gene polymorphisms, particularly CTLA4+6230A/G, and the risk of PTB. The study, conducted by researchers from Srinakharinwirot University, used polymerase chain reaction-restriction fragment length
Antigens
The landscape of cancer treatment is rapidly evolving with the emergence of chimeric antigen receptor (CAR) T-cell therapy, a cutting-edge approach that holds promise for patients with certain types of cancer. Researchers at the City of Hope National Medical Center have highlighted the importance of advanced practice nurses (APNs) in
T cells
The landscape of cancer treatment is rapidly evolving with the emergence of chimeric antigen receptor (CAR) T-cell therapy, a cutting-edge approach that holds promise for patients with certain types of cancer. Researchers at the City of Hope National Medical Center have highlighted the importance of advanced practice nurses (APNs) in
Antigens
A new study from Kumamoto University School of Medicine in Japan has shed light on the rare occurrence of peripheral T-cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy. Researchers investigated a case of a 66-year-old male patient who developed peripheral T-cell lymphoma eight months after receiving CD19-directed CAR
T cells
A new study from Kumamoto University School of Medicine in Japan has shed light on the rare occurrence of peripheral T-cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy. Researchers investigated a case of a 66-year-old male patient who developed peripheral T-cell lymphoma eight months after receiving CD19-directed CAR
Antigens
A new study from Kumamoto University School of Medicine in Japan has shed light on the rare occurrence of peripheral T-cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy. Researchers investigated a case of a 66-year-old male patient who developed peripheral T-cell lymphoma eight months after receiving CD19-directed CAR
